Applications of Nanoparticles in Biomedicine


Applications of Nanoparticles in Biomedicine

Bichitra Nandi Ganguly

Understanding of interactions between nanoparticles and bio-systems is essential for the effective utilization of these materials in biomedicine. A wide variety of nanoparticle surface structures have been developed for imaging, sensing, and drug delivery applications. In this research highlight, advances in tailoring nanoparticle interfaces for implementation in nanomedicine have been discussed. Nanoparticles exhibit unique physical properties such that when their size range commensurate with bio-molecular and cellular systems, their features make them attractive materials for therapeutic and diagnostic applications. Specifically designed nanoparticle monolayer structures can impart enhanced cellular internalization ability, noncytotoxicity and improved payload binding capacity necessary for effective intracellular delivery. Similarly, surface functionality can be tuned to provide the selective or specific recognition required for bio-sensing. Tailoring particle interfaces is a challenging task, chemists have a well-equipped toolbox to provide functionality through synthesis. Using different strategies, nanoparticles have been functionalized with a variety of ligands such as small molecules, surfactants, dendrimers, polymers, and bio-molecules. Biomolecule-conjugated nanoparticles can impart desired properties such as specific recognition or biocompatibility. The ease of such surface conjugation allows material scientists to create the desired functionalities for their future application in clinics. In this article different categories of nanoparticles viz. metal oxide, plasmonic metallic nanoparticles, surface coroneted nanoparticles etc. and their involvement in bio-application have been discussed.

Biomedicine, Therapeutic and Diagnostic Applications, Surface Functionality, Drug-Delivery

Published online 7/1/2018, 18 pages


Part of the book on Nanomaterials in Bio-Medical Applications

[1] A.P. Alivisatos, The use of nanocrystals in biological detection., Nat. Biotechnol. 22 (2004) 47-52.
[2] E. Scott McNeil , Nanotechnology for the biologist., J. Leukoc. Biol. 78(2005) 585–594.
[3] N.L.Rosi, C.A. Mirkin, Nanostructures in bio-diagnostics.Chem.Rev.105 (2005), 1547-1562.
[4] M. Ferrari, Cancer nanotechnology: opportunities and challenges. Nat Rev. Canncer 5(2005),161–171.
[5] V. Wagner, A. Dullaart, A.K. Bock, A. Zweck. The emerging nanomedicine landscape. Nat Biotechnol. 24(2006) 1211-1217.
[6] Y.X.J. Wang, S.M. Hussain, G.P. Krestin, Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur. Radiol. 11 (2001), 2319.
[7] Jae-Hyun Lee , Yong-Min Huh, Young-wook Jun, et al., Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 13(2007), 95-99.
[8] R.G. Panchal, Novel therapeutic strategies to selectively kill cancer cells. Biochem Pharmacol 55 (1998), 247–252.
[9] A Nel, T Xia, L .Madler, N Li., Toxic potential of materials at the nanolevel. Science 311(2006), 622–627.
[10] S Lanone, J. Boczkowski,. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr Mol Med 6( 2006), 651–663.
[11] K .Cho, X .Wang, S. Nie, et al. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res. 14 (2008),1310–1316.
[12] Li SD, Huang L. Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 5(2008) 496-504.
[13] M Ohgaki, T.Kizuki, M. Katsura, K Yamashita, Manipulation of selective cell adhesion and growth by surface charges of electrically polarized hydroxyapatite J Biomed Mater Res. 57( 2001), 366–373.<366::AID-JBM1179>3.0.CO;2-X
[14] S Hong, A .Mecke, et al. Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face? Acc Chem Res. 40 (2007), 335–342.
[15] M.Abercrombie, E.J. Ambrose. The surface properties of cancer cells: a review. Cancer Res. 22 ( 1962) , 525–548.
[16] JOM Bockris, M.A. Habib. Are there electrochemical aspects of cancer? J Biol Physics 10 (1982), 227–237.
[17] N .Papo, M. Shahar, L. Eisenbach, Y. Shai. A novel lytic peptide composed of DL-amino acids selectively kills cancer cells in culture and in mice. J Biol Chem 278 (2003), 21018–21023.
[18] LD Shrode, H. Tapper, S.Grinstein Role of intracellular pH in proliferation, transformation, and apoptosis. J Bioenerg Biomembr .29 (1997), 393–399.
[19] Rich IN, Worthington-White D, Garden OA, Musk P. Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na(+)/H(+) exchanger. Blood 95 ( 2000), 1427–1434.
[20] Y.J .Tang, J.M .Ashcroft, D. Chen, et al. Charge-associated effects of fullerene derivatives on microbial structural integrity and central metabolism. Nano Lett 7 (2007), 754–760.
[21] P. Xu , E.A. Van Kirk, Y Zhan, et al. Targeted charge-reversal nanoparticles for nuclear drug delivery. Angew Chem Int Ed Engl. 46(2007), 4999–5002.
[22] UO Hafeli, JS Riffle, L Harris-Shekhawat, et al. Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol Pharm 6 (2009),1417–28.
[23] WI Hagens, AG Oomen, WH de Jong, et al. What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol 49(2007), 217–229.
[24] W. Shen, H. Xiong, Y. Xu, et al. ZnO-poly(methyl methacrylate) nanobeads for enriching and desalting low-abundant proteins followed by directly MALDI-TOF MS analysis. Anal Chem. 80 ( 2008), 6758–6763.
[25] A Dorfman, O Parajuli, N Kumar, J.I. Hahm Novel telomeric repeat elongation assay performed on zinc oxide nanorod array supports. J Nanosci Nanotechnol 8(2008), 410–415.
[26] H. Lee, E .Lee, K .Kim do, et al. Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. J Am Chem Soc.128( 2006), 7383–7389.
[27] TK Jain, J Richey, M.Strand, et al. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomater.29(2008),4012–4021.
[28] Sreetama Dutta and Bichitra N Ganguly. . Characterization of ZnO nano particles grown in presence of Folic Acid template. J. Nanobiotechnology 10 (2012),29 10pages.
[29] Bichitra Nandi Ganguly, Vivek Verma, Debanuj Chatterjee, Biswarup Satpati, Sushanta Debnath and Partha Saha, . Study of Gallium Oxide Nanoparticles Conjugated with -cyclodextrin -An Application to Combat Cancer, ACS Materials and Interfaces : 8, (2016), 17127- 17131.
[30] Bichitra Nandi Ganguly , Buddhadeb Maity, Tapan Kumar Maity, Joydeb Manna, Modhusudan Roy, Manabendra Mukherjee , Sushanta Debnath, Partha Saha, Nagaraju Shilpa, and Rohit Kumar Rana, . l-Cysteine-Conjugated Ruthenium Hydrous Oxide Nanomaterials with Anticancer Active Application, Langmuir 4 (2018),1447-1456.
[31] M.A. Garcia, Surface plasmons in metallic nanoparticles: fundamentals and applications J. Phys. D: Appl. Phys. 44 (2011) , 283001 (20pages).
[32] P.K. Jain, M.A. El-Sayed, Plasmonic coupling in noble metal nanostructures Chem. Phys. Lett. 487 (2010), 153-164.
[33] Y. Song, W. Wei, X. Qu, Colorimetric biosensing using smart materials, Adv. Mater. 23 (2011), 4215-4236.
[34] R.M. Fratila, Strategies for the biofunctionalization of gold and iron oxide nanoparticles. Langmuir 30 (2014), 15057-71.
[35] P.D. Howes, S. Rana, M.M. Stevens, Plasmonic nanomaterials for biodiagnostics. Chem. Soc. Rev. 43 (2014), 3835-3853.
[36] N.E. Motl, A. F. Smith, C. J. DeSantis and S. E. Skrabalak, Engineering plasmonic metal colloids through composition and structural design. Chem. Soc. Rev. 43 (2014), 3823-3834.
[37] S.M. Lee, et al. Drug-loaded gold plasmonic nanoparticles for treatment of multidrug resistance in cancer. Biomaterials 35 (2014), 2272-2282.
[38] R.A. Alvarez-Puebla, L.M. Liz-Marza´n, Traps and cages for universal SERS detection. Chem. Soc. Rev. 41 (2012), 43-51.
[39] A. Yashchenok, Nanoengineered colloidal probes for Raman-based detection of biomolecules inside living cells Small 9 (2013), 351-356.
[40] H. Xie, Yiyang Lin, Manuel Mazo, Ciro Chiappini, Ana Sánchez-Iglesias, Luis M . Liz-Marzán and Molly M. Stevens, Identification of intracellular gold nanoparticles using surface-enhanced Raman scattering,.Nanoscale 6 (2014),12403-12407.
[41] A Jordan, R Scholz, K. Maier-Hauff, et al. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol (2006)78, 7–14.
[42] A. Jordan, R.Scholz, P .Wust, et al. Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magnetism Magnetic Materials (1999) 201, 413–419.
[43] R. de la Rica, M.M. Stevens, Plasmonic ELISA for the ultrasensitive detection of disease biomarkers with the naked eye. Nat. Nanotechnol. 7 (2012), 821-824.
[44] C.D. Chin, Microfluidics-based diagnostics of infectious diseases in the developing world. Nat. Med. 17 (2011) , 1015-1019.
[45] W. Qu, Copper-mediated amplification allows readout of immunoassays by the naked eye.Angew. Chem. Int. Ed. 50 (2011), 3442-3445.
[46] Y. Xianyu, Z. Wang, X. Jiang, A Plasmonic Nanosensor for Immunoassay via Enzyme-Triggered Click Chemistry. ACS Nano 8 (2014), 12741-1247.
[47] X.M. Nie, Huang R, Dong C-X, Tang L-J, Gui R, Jiang J-H Plasmonic ELISA for the ultrasensitive detection of Treponema pallidum. Biosens. Bioelectron. 58 (2014) 314-319.
[48] M. Coronado-Puchau, Laura Saa, Marek Grzelczak et al., Enzymatic modulation of gold nanorod growth and application to nerve gas detection. Nano Today 8 (2013), 461- 468.
[49] A.S. Thakor, S.S. Gambhir, Nanooncology: the future of cancer diagnosis and therapy. C.A. Cancer, J. Clin. 63 (2013) 395-418.
[50] M. Sivasubramanian, Y. Hsia, L.-W. Lo, anoparticle-facilitated functional and molecular imaging for the early detection of cancer. Front. Mol. Biosci. 1 (2014).
[51] E. Phillips, et al. Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe. Sci. Transl. Med. 6 (2014) 260ra149. TRIAL REGISTRATION: NCT01266096.
[52] J. Llop, V. Go´mez-Vallejo, N. Gibson, Quantitative determination of the biodistribution of nanoparticles: could radiolabeling be the answer? Nanomedicine (Lond.) 8 (2013), 1035-1038.
[53] Bichitra Nandi Ganguly, Nagendra Nath Mondal, Maitreyee Nandy, Frank Roesch, Some Physical Aspects of Positron Annihilation Tomography: a critical review; Journal of Radioanalytical and Nuclear Chemistry 279(2009), 685-698.
[54] C. Pe´rez-Campan˜a, et al. Biodistribution of Different Sized Nanoparticles Assessed by Positron Emission Tomography: A General Strategy for Direct Activation of Metal Oxide Particles. ACS Nano 7 (2013), 3498-3505.